Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8596125rdf:typepubmed:Citationlld:pubmed
pubmed-article:8596125lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0030498lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0063695lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0032150lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0205228lld:lifeskim
pubmed-article:8596125lifeskim:mentionsumls-concept:C0920643lld:lifeskim
pubmed-article:8596125pubmed:issue5lld:pubmed
pubmed-article:8596125pubmed:dateCreated1996-4-18lld:pubmed
pubmed-article:8596125pubmed:abstractTextAfter 4 hours of stimulation of human mononuclear leukocytes in the presence of 300 ng/ml exogenous Plasmodium falciparum antigens, the ICAM-1 expression increased variably from 15% to 375%. Simultaneously, an increase of IL-1 mRNA production could be observed in Northern blot hybridizations with a specific cDNA gene probe for human IL-1 alpha labelled with digoxigenin. Furthermore, the reactive oxygen intermediates (ROI) production was also found to be enhanced in similar conditions. Additionally, when the levels of soluble ICAM-1 (sICAM-1) in plasma of 122 patients with P. falciparum or Plasmodium vivax malaria were analyzed in an enzyme immunoassay (EIA), significant sICAM-1 increases were found, more pronounced in patients with P. falciparum malaria, in comparison with healthy controls and with the same patients 4 weeks after chemotherapy. The presented results indicate that the expression of ICAM-1 may also be upregulated by exogenous Plasmodium antigens besides cytokines like IL-1 during the acute phase of malaria, with subsequently elevated sICAM-1 concentrations in blood.lld:pubmed
pubmed-article:8596125pubmed:languageenglld:pubmed
pubmed-article:8596125pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8596125pubmed:citationSubsetIMlld:pubmed
pubmed-article:8596125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8596125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8596125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8596125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8596125pubmed:statusMEDLINElld:pubmed
pubmed-article:8596125pubmed:monthOctlld:pubmed
pubmed-article:8596125pubmed:issn1120-009Xlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:BienzleUUlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:GraningerWWlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:MetzgerWWlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:ThalhammerFFlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:KremsnerP GPGlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:ZotterG MGMlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:NeiferSSlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:PradaJJlld:pubmed
pubmed-article:8596125pubmed:authorpubmed-author:LehmanL GLGlld:pubmed
pubmed-article:8596125pubmed:issnTypePrintlld:pubmed
pubmed-article:8596125pubmed:volume7lld:pubmed
pubmed-article:8596125pubmed:ownerNLMlld:pubmed
pubmed-article:8596125pubmed:authorsCompleteYlld:pubmed
pubmed-article:8596125pubmed:pagination424-6lld:pubmed
pubmed-article:8596125pubmed:dateRevised2009-8-4lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:meshHeadingpubmed-meshheading:8596125-...lld:pubmed
pubmed-article:8596125pubmed:year1995lld:pubmed
pubmed-article:8596125pubmed:articleTitleUpregulation of ICAM-1, IL-1 and reactive oxygen intermediates (ROI) by exogenous antigens from Plasmodium falciparum parasites in vitro, and of sICAM-1 in the acute phase of malaria.lld:pubmed
pubmed-article:8596125pubmed:affiliationLandesinstitut für Tropenmedizin Berlin, Germany.lld:pubmed
pubmed-article:8596125pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8596125pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8596125pubmed:publicationTypeControlled Clinical Triallld:pubmed